Usefulness of metabolic score for insulin resistance to predict restenosis after coronary stent implantation
Jie Tang, Panpan Xu, Jun Guo, Panpan Hao · 2026
Read Usefulness of metabolic score for insulin resistance to predict restenosis after coronary stent implantation by Jie Tang, Panpan Xu, Jun Guo, Panpan Hao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13250870.txt.
Description
Tang and co-authors test whether a simple metabolic score can warn which heart stents will narrow again. Their 2026 Annals of Medicine study reviews eight hundred eighteen patients who had repeat artery imaging for chest pain after stent placement between 2022 and 2025. The score, called METS-IR, estimates insulin resistance from routine body and blood measures.
Patients whose stents had renarrowed carried clearly higher scores, and renarrowing grew steadily more common across the score thirds. The score stayed an independent predictor after other factors were weighed, with the strongest effect on severe renarrowing. A cutoff value separated risk groups with moderate accuracy. The authors present the score as a cheap, practical way to flag patients needing closer follow-up after stenting.
Catalog record
| CREATOR | Jie Tang, Panpan Xu, Jun Guo, Panpan Hao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |